Quent Capital’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Quent Capital’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1	Closed	-$317	–	1378
2023 Q4	$317	Buy	+1	New	+$194	﹤0.01%	1302

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Quent Capital's KRTX Position: Q1 2024 in Review

Quent Capital sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 1 share — an estimated $317 sold.

Quent Capital first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $317 in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Quent Capital reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Quent Capital sold 1 Karuna Therapeutics, Inc. Common Stock share in Q1 2024, an estimated $317.
Quent Capital first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Quent Capital's Karuna Therapeutics, Inc. Common Stock position peaked at $317 in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Quent Capital's 13F filing for Q1 2024, filed 2 May 2024.